Fig. 1 · Structure
Documents & Downloads
Baxdrostat
Aldosterone Synthase Inhibitor
Baxdrostat is an aldosterone synthase inhibitor that selectively blocks the enzyme involved in the synthesis of aldosterone. By reducing aldosterone levels, Baxdrostat plays a crucial role in the management of conditions characterized by hyperaldosteronism, such as hypertension and heart failure. This reagent is valuable for research applications aimed at investigating the role of aldosterone in cardiovascular and renal diseases.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1428652-17-8 |
| Applications | Aldosterone Synthase Inhibitor |
| Formula | C22H25N3O2 |
| Molecular Weight | 363.45 |
| Synonyms | CIN-107 |
| SMILES | CCC(N[C@H]1C2=CN=CC(C3=CC=C(N(C(CC4)=O)C)C4=C3)=C2CCC1)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.